Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5‐Aminolevulinic Acid–Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial

Documenti analoghi

• Accuracy of photodynamic diagnosis for non‐muscle‐invasive bladder cancer: Exploratory analysis of anatomical locations and tumor types using data from a prospective, single‐arm, multicenter phase III trial
  di: Rikiya Taoka, et al.
  Pubblicazione: (2024)
• Editorial Comment on Variant histology is associated with more non‐urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy
  di: Rikiya Taoka, et al.
  Pubblicazione: (2024)
• Photodynamic Therapeutic Effect during 5‐Aminolevulinic Acid‐Mediated Photodynamic Diagnosis‐Assisted Transurethral Resection of Bladder Tumors
  di: Nobutaka Nishimura, et al.
  Pubblicazione: (2024)
• Preoperative Pyuria as a Predictor of False‐Positive Rates in the Photodynamic Diagnosis of Nonmuscle‐Invasive Bladder Cancer Using Oral 5‐Aminolevulinic Acid
  di: Shinkuro Yamamoto, et al.
  Pubblicazione: (2025)
• How widespread is active surveillance of early‐stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early‐stage prostate cancer in Japan
  di: Takuma Kato, et al.
  Pubblicazione: (2024)